避孕藥市場－全球產業規模、佔有率、趨勢、機會和預測，按藥丸類型、類別、銷售管道、地區和競爭情況細分，2020 年至 2030 年

2024 年全球避孕藥市場價值為 342.1 億美元，預計到 2030 年將達到 506.4 億美元，預測期內的複合年成長率為 6.76%。避孕藥，也稱為節育藥物，專門用於防止懷孕和調節出生率。這些藥物是使用兩種女性荷爾蒙——雌激素和黃體素的組合合成的。透過有效抑制排卵，這些激素在防止卵巢排卵方面起著至關重要的作用。避孕藥不僅可以防止排卵，還可以使子宮頸黏液變稠，使精子更難到達卵子進行受精。此外，它們還可以改變子宮內膜，創造不利於受精卵著床的環境。透過針對這些關鍵機制，避孕藥提供了一種非常有效的避孕方法。除了預防意外懷孕的主要目的外，避孕藥還有其他一些好處。研究發現，避孕藥可以降低痤瘡、骨質疏鬆症以及某些癌症（例如卵巢癌）的風險。此外，避孕藥還可以幫助預防輸卵管和子宮感染，並緩解經前症候群（PMS）的症狀。

鑑於避孕藥對女性生殖健康的重大影響，其通常由醫療保健從業人員開立處方並給藥。這些藥物有多種劑型，包括口服藥、注射劑和外用劑，為女性提供一系列可根據個人需求和偏好選擇的方案。隨著醫學研究和技術的不斷進步，避孕藥領域也在不斷發展，為女性提供了更多選擇，並提高了預防意外懷孕的有效性。根據聯合國性與生殖健康機構人口基金發布的《2022年世界人口狀況報告》，全球每年有近1.21億例懷孕，幾乎佔總數的一半，是意外懷孕。

關鍵市場促進因素

人口控制計劃的增加

主要市場挑戰

設備和治療費用高昂

主要市場趨勢

非荷爾蒙替代品

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球避孕藥市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按藥丸類型（孕激素藥丸和複合藥丸）
  • 按類別（通用和品牌）
  • 依銷售管道（醫院藥局、零售藥局、網路藥局）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美避孕藥市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲避孕藥市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太避孕藥市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲避孕藥市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲避孕藥市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 併購
• 產品發布

第 13 章：全球避孕藥市場：SWOT 分析

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章：競爭格局

• Bayer AG
• Amneal Pharmaceuticals LLC
• Teva Pharmaceuticals Industries Ltd.
• Abbvie Inc. (Allergan PLC)
• Pfizer Inc.
• Johnson & Johnson
• Aurobindo Pharma Limited
• Organon International (Merck & Co. Inc.)
• Sanofi SA
• Mayne Pharma Group Ltd

第 16 章：策略建議

第17章調查會社について,免責事項

Global Contraceptive Pills Market has valued at USD 34.21 Billion in 2024 and is expected to reach USD 50.64 Billion by 2030 with a CAGR of 6.76% during the forecast period. Contraceptive pills, also known as birth control medications, are specifically designed to prevent pregnancy and regulate birth rates. These medications are synthetically formulated using a combination of two female hormones, estrogen and progestin. By effectively inhibiting ovulation, these hormones play a crucial role in preventing the release of eggs from the ovaries. Contraceptive pills not only prevent ovulation but also thicken the cervical mucus, making it more difficult for sperm to reach the egg for fertilization. Additionally, they can alter the lining of the womb, creating an environment that is unfavorable for the implantation of a fertilized egg. By targeting these key mechanisms, contraceptive pills provide a highly effective means of birth control. In addition to their primary purpose of preventing unwanted pregnancies, contraceptive pills offer several other benefits. They have been found to reduce the risks of acne, bone thinning, and certain types of cancers, such as ovarian cancer. Moreover, they can help prevent infections in the fallopian tubes and uterus, as well as alleviate symptoms of premenstrual syndrome (PMS).

Given their significant impact on women's reproductive health, contraceptive pills are typically prescribed and administered by healthcare practitioners. These medications are available in various forms, including oral pills, injectables, and topical formulations, providing women with a range of options to choose from based on their individual needs and preferences. With ongoing advancements in medical research and technology, the field of contraceptive pills continues to evolve, offering women more choices and improved effectiveness in preventing unplanned pregnancies. According to the State of World Population 2022 report by UNFPA, the United Nations sexual and reproductive health agency, nearly 121 million pregnancies globally each year-almost half of the total-are unintended.

Key Market Drivers

Increase in Population Control Program

The efforts made by governments to reduce population growth in various nations are not only raising women's understanding of family planning and contraception, but also bringing about significant changes in both urban and rural settings. In industrialized markets, the use of oral contraceptives has witnessed a substantial increase due to the rising occurrence of unintended pregnancies, prompting individuals to take proactive measures for contraception. As the population continues to expand at a rapid rate, particularly in Asian countries, the micro-level impact on the socio-economic balance becomes more evident. Recognizing the urgency of the situation, public and private players are joining hands to effectively manage the population growth, with a vision of bringing about a positive transformation in sex education and contraception use in the years to come. It is anticipated that these collaborative efforts will not only drive the market CAGR for contraceptive pills but also result in an overall improvement in healthcare outcomes. Thus, the revenue from the contraceptive pills market is predicted to experience a steady increase throughout the forecast period, reflecting the growing importance of addressing population growth and advancing reproductive health worldwide. For instance, in July 2023, the Karnataka Health Department in India introduced two new contraceptive methods for women as part of the National Family Planning Programme. The sub-dermal implant and subcutaneous injection were introduced in government-run health centers to promote reproductive and sexual health by increasing the gap between two births.

Key Market Challenges

High Cost of Devices and Treatment

The high cost of devices and treatment options is having a notable impact on the demand for contraceptive pills, creating financial barriers that hinder access for many individuals and couples. This trend reflects a complex interplay of economic factors that are shaping choices in reproductive healthcare. One of the primary reasons for the decreasing demand for contraceptive pills is the substantial upfront cost associated with alternative contraceptive methods. Devices such as intrauterine devices (IUDs) or contraceptive implants, while highly effective, often require a significant initial investment for insertion or implantation. This cost can be prohibitive for individuals without adequate insurance coverage or financial resources, causing them to opt for less expensive alternatives, including contraceptive pills.

Furthermore, ongoing maintenance and follow-up costs for certain contraceptive devices can add to the financial burden. For example, IUDs may require periodic check-ups or replacements, incurring additional expenses over time. In contrast, contraceptive pills have the advantage of a more predictable and manageable monthly cost, making them a more financially accessible option for many.

In addition to device costs, the expense of medical consultations and treatments associated with certain contraceptive methods can dissuade individuals from pursuing those options. Procedures like sterilization or permanent contraception can be costly and may not be covered by insurance, making them inaccessible for those with limited financial means. As a result, contraceptive pills, which are available with a prescription but typically require fewer medical interventions, remain a more affordable choice for many.

However, it's important to note that the declining demand for contraceptive pills due to high device and treatment costs is not uniform across all populations. In some cases, individuals and couples who can afford the upfront costs of more effective devices may choose them over contraceptive pills, leading to variations in contraceptive choices based on economic status. The high cost of contraceptive devices and associated treatments is indeed reducing the demand for contraceptive pills, particularly among individuals and couples with limited financial resources. While contraceptive pills offer an affordable and accessible option, addressing the financial barriers to alternative methods is crucial to ensuring equitable access to a wide range of contraceptive choices for all individuals, regardless of their economic circumstances.

Key Market Trends

Non-Hormonal Alternative

Growing concerns about hormonal side effects may lead to increased demand for non-hormonal contraceptive pills. Innovations in this area might include non-hormonal oral contraceptives or alternative delivery methods. Growing concerns about hormonal side effects associated with traditional contraceptive pills are indeed driving an increased demand for non-hormonal contraceptive options. This trend reflects a growing desire among individuals to have contraceptive choices that minimize hormonal interventions and their potential side effects. Research and development efforts are focused on creating non-hormonal oral contraceptive pills that are effective at preventing pregnancy without altering hormonal balances. These may include pills containing novel active ingredients that target fertility mechanisms without affecting hormones.

Advancements in drug delivery technology may lead to alternative methods of delivering non-hormonal contraceptives, such as patches, gels, or vaginal rings. Innovations in emergency contraception may offer non-hormonal alternatives for preventing pregnancy after unprotected intercourse, providing more options to those who wish to avoid hormonal interventions.

Key Market Players

• Bayer AG
• Amneal Pharmaceuticals LLC
• Teva Pharmaceuticals Industries Ltd.
• Abbvie Inc. (Allergan PLC)
• Pfizer Inc.
• Johnson & Johnson
• Aurobindo Pharma Limited
• Organon International (Merck & Co. Inc.)
• Sanofi SA
• Mayne Pharma Group Ltd

Report Scope:

In this report, the Global Contraceptive Pills Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contraceptive Pills Market, By Pill Type:

• Progestin Pills
• Combination Pills

Contraceptive Pills Market, By Category:

• Generic
• Branded

Contraceptive Pills Market, By Sales Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Contraceptive Pills Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Contraceptive Pills Market.

Available Customizations:

Global Contraceptive Pills market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Contraceptive Pills Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Pill Type (Progestin Pills & Combination Pills)
  • 5.2.2. By Category (Generic & Branded)
  • 5.2.3. By Sales Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Contraceptive Pills Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Pill Type
  • 6.2.2. By Category
  • 6.2.3. By Sales Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Contraceptive Pills Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Pill Type
      • 6.3.1.2.2. By Category
      • 6.3.1.2.3. By Sales Channel
  • 6.3.2. Canada Contraceptive Pills Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Pill Type
      • 6.3.2.2.2. By Category
      • 6.3.2.2.3. By Sales Channel
  • 6.3.3. Mexico Contraceptive Pills Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Pill Type
      • 6.3.3.2.2. By Category
      • 6.3.3.2.3. By Sales Channel

7. Europe Contraceptive Pills Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Pill Type
  • 7.2.2. By Category
  • 7.2.3. By Sales Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Contraceptive Pills Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Pill Type
      • 7.3.1.2.2. By Category
      • 7.3.1.2.3. By Sales Channel
  • 7.3.2. United Kingdom Contraceptive Pills Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Pill Type
      • 7.3.2.2.2. By Category
      • 7.3.2.2.3. By Sales Channel
  • 7.3.3. Italy Contraceptive Pills Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Pill Type
      • 7.3.3.2.2. By Category
      • 7.3.3.2.3. By Sales Channel
  • 7.3.4. France Contraceptive Pills Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Pill Type
      • 7.3.4.2.2. By Category
      • 7.3.4.2.3. By Sales Channel
  • 7.3.5. Spain Contraceptive Pills Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Pill Type
      • 7.3.5.2.2. By Category
      • 7.3.5.2.3. By Sales Channel

8. Asia-Pacific Contraceptive Pills Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Pill Type
  • 8.2.2. By Category
  • 8.2.3. By Sales Channel
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Contraceptive Pills Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Pill Type
      • 8.3.1.2.2. By Category
      • 8.3.1.2.3. By Sales Channel
  • 8.3.2. India Contraceptive Pills Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Pill Type
      • 8.3.2.2.2. By Category
      • 8.3.2.2.3. By Sales Channel
  • 8.3.3. Japan Contraceptive Pills Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Pill Type
      • 8.3.3.2.2. By Category
      • 8.3.3.2.3. By Sales Channel
  • 8.3.4. South Korea Contraceptive Pills Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Pill Type
      • 8.3.4.2.2. By Category
      • 8.3.4.2.3. By Sales Channel
  • 8.3.5. Australia Contraceptive Pills Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Pill Type
      • 8.3.5.2.2. By Category
      • 8.3.5.2.3. By Sales Channel

9. South America Contraceptive Pills Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Pill Type
  • 9.2.2. By Category
  • 9.2.3. By Sales Channel
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Contraceptive Pills Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Pill Type
      • 9.3.1.2.2. By Category
      • 9.3.1.2.3. By Sales Channel
  • 9.3.2. Argentina Contraceptive Pills Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Pill Type
      • 9.3.2.2.2. By Category
      • 9.3.2.2.3. By Sales Channel
  • 9.3.3. Colombia Contraceptive Pills Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Pill Type
      • 9.3.3.2.2. By Category
      • 9.3.3.2.3. By Sales Channel

10. Middle East and Africa Contraceptive Pills Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Pill Type
  • 10.2.2. By Category
  • 10.2.3. By Sales Channel
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Contraceptive Pills Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Pill Type
      • 10.3.1.2.2. By Category
      • 10.3.1.2.3. By Sales Channel
  • 10.3.2. Saudi Arabia Contraceptive Pills Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Pill Type
      • 10.3.2.2.2. By Category
      • 10.3.2.2.3. By Sales Channel
  • 10.3.3. UAE Contraceptive Pills Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Pill Type
      • 10.3.3.2.2. By Category
      • 10.3.3.2.3. By Sales Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Contraceptive Pills Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bayer AG
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Amneal Pharmaceuticals LLC
• 15.3. Teva Pharmaceuticals Industries Ltd.
• 15.4. Abbvie Inc. (Allergan PLC)
• 15.5. Pfizer Inc.
• 15.6. Johnson & Johnson
• 15.7. Aurobindo Pharma Limited
• 15.8. Organon International (Merck & Co. Inc.)
• 15.9. Sanofi SA
• 15.10. Mayne Pharma Group Ltd

16. Strategic Recommendations

17. About Us & Disclaimer